Denver, CO · Founded 2019 · Privately Held (backing)
Developer of a remote patient monitoring device designed to enhance healthcare delivery. BioIntelliSense is based in Denver, CO and was founded in 2019. Its last reported valuation was $1.2 billion in Dec 2022. It has raised $319 million across 4 recorded rounds; the latest was a $58.3 million later-stage round in Dec 2025.
Last reported valuation
$1.2B
Oct 2026
Priced at
—
Total raised
$318.6M
Last round
Later Stage VC
Dec 2025
Team — not yet on record
No current team members for BioIntelliSense are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BioIntelliSense with a free account
·The complete investor list: 18 names
·Watch BioIntelliSense: the Monday email on marks, rounds and moves
